Sepsis outbreak following a probable extrinsic contamination of propofol by Escherichia coli, Geneva, 2024

Over a 14-day period, four patients developed sepsis within hours of undergoing endoscopic procedures at a gastroenterology outpatient clinic in Geneva (Switzerland), triggering an urgent epidemiological investigation upon notification to authorities. The case clustering raised concerns about a iatrogenic source, prompting a coordinated public health response. This report outlines the investigation led by the Geneva Health Authorities in collaboration with the medical team, emergency care providers, infection prevention specialists, and the bacteriology laboratory at Geneva University Hospitals. A multidisciplinary team, including an epidemiologist, a pharmacist and an infection prevention specialist, conducted an on-site investigation the day after the outbreak was identified, highlighting a probable extrinsic contamination of propofol by Escherichia coli.

Authors

Institutions

Publication Details

Journal
Antimicrobial Resistance and Infection Control
Published
2025-12-24
DOI
https://doi.org/10.1186/s13756-025-01655-x
Primary Topic
Medical Device Sterilization and Disinfection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sepsis outbreak following a probable extrinsic contamination of propofol by Escherichia coli, Geneva, 2024

Alessandro Cassini, Aliki Metsini, Sophie Garcin, Roberta Petrucci et al.
Antimicrobial Resistance and Infection Control
Medical Device Sterilization and Disinfection
article

Sepsis outbreak following a probable extrinsic contamination of propofol by Escherichia coli, Geneva, 2024

Alessandro Cassini, Aliki Metsini, Sophie Garcin, Roberta Petrucci, Diem-Lan VU, S. Harbarth, Simon Regard, Nechan Haroutunian, Jacques Schrenzel, Delphine Perréard, Olivier Grosgurin, Abdessalam Cherkaoui, Nathalie Vernaz, Amir Allaoua, Vladimir Lazarevic
article en

Abstract

Over a 14-day period, four patients developed sepsis within hours of undergoing endoscopic procedures at a gastroenterology outpatient clinic in Geneva (Switzerland), triggering an urgent epidemiological investigation upon notification to authorities. The case clustering raised concerns about a iatrogenic source, prompting a coordinated public health response. This report outlines the investigation led by the Geneva Health Authorities in collaboration with the medical team, emergency care providers, infection prevention specialists, and the bacteriology laboratory at Geneva University Hospitals. A multidisciplinary team, including an epidemiologist, a pharmacist and an infection prevention specialist, conducted an on-site investigation the day after the outbreak was identified, highlighting a probable extrinsic contamination of propofol by Escherichia coli.

Antimicrobial Resistance and Infection ControlVol. 14(1)
University of Geneva (CH), University Hospital of Geneva (CH), Department of Health Canton of Zurich (CH), Geneva College (US)
Good health and well-being
Openalex Percentile: Top 32%
Medical Device Sterilization and Disinfection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Sepsis outbreak following a probable extrinsic contamination of propofol by Escherichia coli, Geneva, 2024 — Alessandro Cassini, Aliki Metsini, et al. · Antimicrobial Resistance and Infection Control (2025) | TGRS Research Map | TGRS